Literature DB >> 18652591

Chordoid glioma: a case report and molecular characterization of five cases.

Craig Horbinski1, Sanja Dacic, Roger E McLendon, Kathy Cieply, Michael Datto, Daniel J Brat, Charleen T Chu.   

Abstract

Chordoid gliomas are rare, slow-growing neoplasms of the anterior third ventricle. We reported a case of chordoid glioma in a 41-year-old man with obstructive hydrocephalus. Histologically, the tumor consisted of polygonal epithelioid cells admixed with elongated cells in a myxoid stroma. A prominent lymphoplasmacytic infiltrate was present. The tumor cells expressed glial fibrillary acidic protein (GFAP), epithelial membrane antigen (EMA), vimentin, CD31, CD34, epidermal growth factor receptor (EGFR) and S100 but were negative for pankeratin and E-cadherin. The percentage of Ki67 positive cells was approximately 3%. Weak p53 immunoreactivity was seen in less than 10% of the cells. Array comparative genomic hybridization performed on this case, as well as on four other archived cases, showed losses at several loci. Fluorescence in situ hybridization (FISH) confirmed consistent genetic alterations at 9p21 and 11q13. These are the fifth through ninth reported cases of chordoid gliomas with molecular characterization suggesting a distinct genetic origin from other gliomas.

Entities:  

Mesh:

Year:  2008        PMID: 18652591     DOI: 10.1111/j.1750-3639.2008.00196.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  9 in total

Review 1.  Prognostic factors for recurrence and complications in the surgical management of primary chordoid gliomas: A systematic review of literature.

Authors:  Leonel Ampie; Winward Choy; Jonathan B Lamano; Kartik Kesavabhotla; Qinwen Mao; Andrew T Parsa; Orin Bloch
Journal:  Clin Neurol Neurosurg       Date:  2015-08-19       Impact factor: 1.876

2.  The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.

Authors:  Craig Horbinski; Gerard J Oakley; Kathleen Cieply; Geeta S Mantha; Marina N Nikiforova; Sanja Dacic; Raja R Seethala
Journal:  Arch Pathol Lab Med       Date:  2010-08       Impact factor: 5.534

3.  Chordoid glioma of the third ventricle: report of a rapidly progressive case.

Authors:  Amalie A Erwood; Jose E Velazquez-Vega; Stewart Neill; David A Solomon; Nicholas Butowski; Adam Nowlan; Erin Dunbar; Daniel J Brat
Journal:  J Neurooncol       Date:  2017-03-18       Impact factor: 4.130

Review 4.  Chordoid glioma of the third ventricle: a patient presenting with SIADH and a review of this rare tumor.

Authors:  Matilde Calanchini; Simon Cudlip; Monika Hofer; James Byrne; Andrea Fabbri; Ashley Grossman
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

5.  YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.

Authors:  Craig Horbinski; Guoji Wang; Clayton A Wiley
Journal:  Int J Clin Exp Pathol       Date:  2010-01-01

6.  Chordoid glioma : a case report of unusual location and neuroradiological characteristics.

Authors:  Jin Wook Kim; Jae Hyoung Kim; Gheeyoung Choe; Chae-Yong Kim
Journal:  J Korean Neurosurg Soc       Date:  2010-07-31

Review 7.  Major Features of the 2021 WHO Classification of CNS Tumors.

Authors:  Heather L Smith; Nitin Wadhwani; Craig Horbinski
Journal:  Neurotherapeutics       Date:  2022-05-16       Impact factor: 7.620

8.  One of a kind-chordoid glioma in the fourth ventricle: a case report and literature review.

Authors:  Yat Sing Lee; Tsz Wai Yeung; On Cheung Leung
Journal:  Acta Radiol Open       Date:  2020-12-14

9.  A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle.

Authors:  Benjamin Goode; Gourish Mondal; Michael Hyun; Diego Garrido Ruiz; Yu-Hsiu Lin; Jessica Van Ziffle; Nancy M Joseph; Courtney Onodera; Eric Talevich; James P Grenert; Iman H Hewedi; Matija Snuderl; Daniel J Brat; Bette K Kleinschmidt-DeMasters; Fausto J Rodriguez; David N Louis; William H Yong; M Beatriz Lopes; Marc K Rosenblum; Nicholas Butowski; Tarik Tihan; Andrew W Bollen; Joanna J Phillips; Arun P Wiita; Iwei Yeh; Matthew P Jacobson; Boris C Bastian; Arie Perry; David A Solomon
Journal:  Nat Commun       Date:  2018-02-23       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.